Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.
Neuro3 Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
Neuro3 Therapeutics's investors include Qiming Venture Partners, Jiangsu NHWA Pharmaceutical.
Neuro3 Therapeutics is headquartered in Hong Kong, Hong Kong.
Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.
Neuro3 Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuro3 Therapeutics — Funding & Investors." VCBacked, March 6, 2025, https://www.vcbacked.co/company/neuro3-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). Neuro3 Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/neuro3-therapeutics
{{cite web |title=Neuro3 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuro3-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated